GoldenPeaks Capital Holding Ltd. / Key word(s): Agreement GoldenPeaks Capital and Reckitt have signed a 10-year Power Purchase Agreement in Poland. 21.05.2024 / 14:00 CET/CEST Warsaw, May 21, 2024 - GoldenPeaks Capital and Reckitt have signed a 10-year Power Purchase Agreement in Poland, promoting further decarbonization of the country’s grid and helping Reckitt meet its green goals. GoldenPeaks Capital, one of the fastest growing independent power producers in Eastern Europe, continues its mission to help corporates in their carbon reduction efforts. The power purchase agr...
GoldenPeaks Capital Holding Ltd. / Schlagwort(e): Vereinbarung GoldenPeaks Capital und Reckitt haben in Polen einen Stromabnahmevertrag mit einer Laufzeit von 10 Jahren unterzeichnet. 21.05.2024 / 14:00 CET/CEST Warschau, 21. Mai 2024 – GoldenPeaks Capital und Reckitt haben in Polen einen Stromabnahmevertrag mit einer Laufzeit von 10 Jahren unterzeichnet, der die weitere Dekarbonisierung des Stromnetzes des Landes vorantreibt und Reckitt dabei hilft, seine grünen Ziele zu erreichen. GoldenPeaks Capital, einer der am schnellsten wachsenden unabhängigen Stromerzeuger in Osteu...
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces data from a poster presented at Digestive Disease Week (DDW2024) demonstrating the potential of the Company’s lead clinical-stage compound, FXR314, in combination with tofaciti...
Pyxis Tankers Announces Joint Venture Agreement to Acquire Modern Dry-Bulk Vessel, Expansion of Common Share Repurchase Program & Partial Redemption of Series A Cumulative Convertible Preferred Stock Maroussi, Greece – May 21, 2024 – Pyxis Tankers Inc. (NASDAQ Cap Mkts: PXS), (“we”, “our”, “us”, the “Company” or “Pyxis Tankers”), an international shipping company, announced today key strategic and financial actions to further enhance its shareholder value. The Company has entered into an agreement with a group of sellers, including the Company’s Chairman and Chief Executive Officer, Mr...
Karat Packaging to Participate in Two June Investor Conferences CHINO, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Karat Packaging Inc. (Nasdaq: KRT) (“Karat”), a specialty distributor and manufacturer of disposable foodservice products and related items, today announced that it will participate in two investor conferences in June. On June 4, 2024 at 11:30 a.m. ET, Karat’s Chief Executive Officer Alan Yu and Chief Financial Officer Jian Guo will participate in a fireside chat at the Stifel 2024 Cross Sector Insight Conference, taking place at the InterContinental Boston Hotel. On June 5, 2...
Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapanor), a First-In-Class Treatment for IBS-C in Adults WALTHAM, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that data supporting additional positive clinical observations of IBSRELA® (tenapanor) was presented at the 2024 Digestive Disease Week Conference (DDW), currently taking place in...
EQS-News: technotrans SE / Schlagwort(e): Sonstiges Batteriekühlsysteme für neue E-Busse: technotrans sichert sich Großauftrag 21.05.2024 / 13:57 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Batteriekühlsysteme für neue E-Busse: technotrans sichert sich Großauftrag Großvolumenauftrag im hohen einstelligen Millionen-Euro-Bereich Serienfertigung von Batterie-Thermomanagement-Systemen (BTMS) für mehrere E-Bus-Serien Wachstumsbeschleuniger im technotrans-Fokusmarkt Energy Management und Meilenstein im Segment Straßenfahrzeuge Sassen...
EQS-News: technotrans SE / Key word(s): Miscellaneous Battery cooling systems for new e-buses: technotrans secures major order 21.05.2024 / 13:57 CET/CEST The issuer is solely responsible for the content of this announcement. Battery cooling systems for new e-buses: technotrans secures major order Large-volume order in the high single-digit million euro range Series production of battery thermal management systems (BTMS) for several e-bus series Growth accelerator in technotrans' focus market Energy Management and milestone in the road vehicles segment Sassenberg, 21 M...
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK)Alvotech will be responsible for development and manufacture of the product HYDERABAD, INDIA & REYKJAVIK, ICELAND — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Red...
Alvotech gengur til samstarfs við Dr. Reddy‘s um markaðssetningu AVT03, fyrirhugaðrar hliðstæðu við Prolia og Xgeva, í Bandaríkjunum og Evrópu Alvotech (NASDAQ: ALVO) tilkynnti í dag að fyrirtækið hefði gert samstarfssamning við Dr. Reddy’s Laboratories SA, dótturfyrirtæki Dr. Reddy’s Laboratories Ltd. (“Dr. Reddy’s”) um sölu- og markaðssetningu AVT03, fyrirhugaðrar líftæknilyfjahliðstæðu Alvotech við Prolia og Xgeva, sem bæði innnihalda denosumab. Dr. Reddy er alþjóðlegt lyfjafyrirtæki með höfuðstöðvar á Indlandi en starfsemi um allan heim. Prolia og Xgeva eru líftæknilyf við ýmsum þr...
KANZHUN LIMITED Announces Board Changes BEIJING, May 21, 2024 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HKEX: 2076), a leading online recruitment platform in China, today announced that Ms. Shangyu Gao has resigned as an independent non-executive director of the Company in order to devote more time to her other personal business commitments, effective on May 21, 2024. In addition, with effect from May 21, 2024, Ms. Mengyuan Dong has been appointed as an independent non-executive director of the Company, the chairman of the audit committee, a member...
Alarum Announces Q1 2024 Results First quarter record revenues of $8.4 Million, up 47% year over year; IFRS gross margin climbed to 78% compared to 66% for the first quarter of last year IFRS net profit was $1.4 million while non-IFRS net profit surged to $2.8 million; Earnings per American Depository Share (EPS) of $0.23 and $0.45, respectively Adjusted EBITDA reached a record of $3.2 million Subsidiary NetNut’s revenues in the first quarter jumped 139% year over year; Net Retention Rate (“NRR”) increased to 1.66 TEL AVIV, Israel, May 21, 2024 (GLOBE NEWSWIRE) -- (N...
Allegro MicroSystems Expands Isolated Gate Driver Portfolio with Power-Thru Combo Chip New Product Provides Engineers with Greater Flexibility in Designing for Higher Power Output in EV Chargers MANCHESTER, N.H., May 21, 2024 (GLOBE NEWSWIRE) -- (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing solutions for motion control and energy-efficient systems, today announced the launch of the third product in its High Voltage Power-Thru™ portfolio. Allegro’s two-chip isolated gate-driver IC solutions work together with external transformers to provide the freedom to design and...
Alvotech and Dr. Reddy’s enter into collaboration for commercialization of AVT03 (denosumab), a biosimilar candidate to Prolia® & Xgeva® in the U.S., Europe and UK Dr. Reddy’s gets exclusive commercialization rights in the United States (U.S.) as well as semi-exclusive rights in Europe and United Kingdom (UK) Alvotech will be responsible for development and manufacture of the product HYDERABAD, India and REYKJAVIK, Iceland, May 21, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines fo...
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit EDINBURGH, United Kingdom, May 21, 2024 (GLOBE NEWSWIRE) -- NuCana plc (Nasdaq: NCNA) announced today that Hugh Griffith, Chief Executive Officer, and Don Munoz, Chief Financial Officer, will present at TD Cowen’s 5th Annual Oncology Innovation Summit: Insights for ASCO & EHA. Event: TD Cowen’s 5th Annual Oncology Innovation SummitDate: Tuesday, May 28, 2024Time: 8:30 AM EDTLocation: Virtual The presentation will be webcast live and available for replay under “Events & Presentations” in the Investors section of the Co...
Freshpet, Inc. to Participate in the Deutsche Bank Global Consumer Conference SECAUCUS, N.J., May 21, 2024 (GLOBE NEWSWIRE) -- Freshpet, Inc. (“Freshpet” or the “Company”) (Nasdaq: FRPT) today announced that members of the executive management team will participate in the Deutsche Bank Global Consumer Conference in Paris, France. The presentation will be on Tuesday, June 4, 2024 at 12:00 p.m. CEST / 6:00 a.m. EDT. A live webcast and replay will be available on the "Investors" section of the Company's website at . About Freshpet Freshpet’s mission is to improve the lives of dogs and ca...
Tempest to Participate in Upcoming Investor Conferences BRISBANE, Calif., May 21, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-classi targeted and immune-mediated therapeutics to fight cancer, today announced that management will participate in the following upcoming investor conferences: TD Cowen's 5th Annual Oncology Innovation Summit – Fireside chat on Wednesday, May 29, 2024 at 2:00 p.m. ET Jefferies Global Healthcare Conference – Presentation on Wednesday, June 5, 2024 at 4:00 p.m. ET To access the l...
Tonix Pharmaceuticals Announces Key Findings from Initial Phase of EVERSANA Market Opportunity Analysis for Tonmya™ for the Management of Fibromyalgia Tonmya is a potential new first-line, centrally acting non-opioid analgesic for the management of fibromyalgia, supported by statistically significant results from two Phase 3 trials Primary physician research found high level of interest in Tonmya as a potential new treatment option for fibromyalgia Significant dissatisfaction reported with drugs currently approved by FDA for the treatment of fibromyalgia Analysis of claims data rev...
Fundamental Global Inc. Declares Cash Dividend on Its 8.00% Cumulative Preferred Stock, Series A Mooresville, NC, May 21, 2024 (GLOBE NEWSWIRE) -- Fundamental Global Inc. (Nasdaq: FGF, FGFPP) (the “Company” or "Fundamental Global"), formerly known as FG Financial Group, Inc., today announced that it has declared a quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A (the “Preferred Stock”), for the period commencing on March 15, 2024, and ending on June 14, 2024. In accordance with the terms of the Preferred Stock, the board of directors of the Company declared a ...
Kandi 10K All-Electric UTV Model Achieves EU EEC Certification JINHUA, CHINA, May 21, 2024 (GLOBE NEWSWIRE) -- Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) (“Kandi” or the “Company”), a leading distributor of all-electric personal transportation and utility vehicles, today announced the certification of its 10K all-electric UTV model by the European Economic Community (EEC). This achievement confirms that the product meets the European Union's high standards for safety, quality, and performance, preparing it for its market debut within the EU. 10K All-Electric UTV ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.